https://www.healio.com/news/endocrinology/20230624/surmount2-tirzepatide-confers-about-15-weight-loss-in-adults-with-obesity-and-diabetes
0
0
6/24/23 at 2:28pm
Organization
Healio
Authors
SAN DIEGO — Adults with obesity and type 2 diabetes achieved a 14.7% weight loss at 72 weeks with 15 mg tirzepatide, according to data from the SURMOUNT-2 trial presented at the American Diabetes Association Scientific Sessions.In a phase 3 randomized c…
Create an account
or login to join the discussion